Modulation of the PD-1 pathway by inhibitory antibody superagonists

Modulation of the PD-1 pathway by inhibitory antibody superagonists

<p>In metozoans, most of the key events that lead to cell activation and inhibition are controlled by tyrosine phosphorylation. Extracellular signals are transmitted by membrane bound receptors, which have intrinsic kinase activity or themselves recruit intracellular kinases to specialised inh...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoir:	Akkaya, B
Rannpháirtithe:	Davis, S
Formáid:	Tráchtas
Teanga:	English
Foilsithe / Cruthaithe:	2012
Ábhair:	Immunology

Míreanna comhchosúla

Second generation superagonistic anti-PD-1 antibodies
de réir: Yu, SY
Foilsithe / Cruthaithe: (2019)

Inhibitory superagonistic antibodies as novel therapeutics
de réir: Donat, RF
Foilsithe / Cruthaithe: (2023)

In vivo characterization of inhibitory anti-PD-1 antibody superagonists
de réir: Akkaya, B, et al.
Foilsithe / Cruthaithe: (2011)

Regulation of human and mouse bystander T cell activation responses by PD-1
de réir: Catherine T. Le, et al.
Foilsithe / Cruthaithe: (2023-09-01)

Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist
de réir: Jeffrey Schlom, et al.
Foilsithe / Cruthaithe: (2020-05-01)

Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling
de réir: Ling Ding, et al.
Foilsithe / Cruthaithe: (2023-01-01)

PD-L1 restrains PD-1+Nrp1lo Treg cells to suppress inflammation-driven colorectal tumorigenesis
de réir: Dakota B. Poschel, et al.
Foilsithe / Cruthaithe: (2024-10-01)

Lysosomal acid lipase, CSF1R, and PD-L1 determine functions of CD11c+ myeloid-derived suppressor cells
de réir: Ting Zhao, et al.
Foilsithe / Cruthaithe: (2022-09-01)

Topological requirements and signaling properties of T cell-activating, anti-CD28 antibody superagonists.
de réir: Lühder, F, et al.
Foilsithe / Cruthaithe: (2003)

Glioblastoma extracellular vesicles modulate immune PD-L1 expression in accessory macrophages upon radiotherapy
de réir: Markus W. Schweiger, et al.
Foilsithe / Cruthaithe: (2024-02-01)

PD-1 deficiency impairs eosinophil recruitment to tissue during Trichinella spiralis infection
de réir: Yiqi Liu, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Modulation of regulatory T cell function through specific molecular pathways in transplantation
de réir: Kawai, K
Foilsithe / Cruthaithe: (2020)

Immune tolerance against infused FVIII in hemophilia A is mediated by PD-L1+ Tregs
de réir: Janine Becker-Gotot, et al.
Foilsithe / Cruthaithe: (2022-11-01)

Chronic viral infection alters PD-1 locus subnuclear localization in cytotoxic CD8+ T cells
de réir: Catarina Sacristán, et al.
Foilsithe / Cruthaithe: (2024-08-01)

Single-cell characterization of anti–LAG-3 and anti–PD-1 combination treatment in patients with melanoma
de réir: Jani Huuhtanen, et al.
Foilsithe / Cruthaithe: (2023-03-01)

Context-restricted PD-(L)1 checkpoint agonism by CTLA4-Ig therapies inhibits T cell activity
de réir: Ethan P. Oxley, et al.
Foilsithe / Cruthaithe: (2024-10-01)

Batf3+ DCs and the 4-1BB/4-1BBL axis are required at the effector phase in the tumor microenvironment for PD-1/PD-L1 blockade efficacy
de réir: Andrea Ziblat, et al.
Foilsithe / Cruthaithe: (2024-05-01)

IRF4 impedes human CD8 T cell function and promotes cell proliferation and PD-1 expression
de réir: Thibault Hirsch, et al.
Foilsithe / Cruthaithe: (2024-07-01)

Long noncoding RNA HITT coordinates with RGS2 to inhibit PD-L1 translation in T cell immunity
de réir: Qingyu Lin, et al.
Foilsithe / Cruthaithe: (2023-06-01)

Generation of bispecific antibodies by structure-guided redesign of IgG constant regions
de réir: Iwasaki, Yordkhwan W., et al.
Foilsithe / Cruthaithe: (2023)

Identification of a PD-L1+Tim-1+ iNKT subset that protects against fine particulate matter–induced airway inflammation
de réir: Christina Li-Ping Thio, et al.
Foilsithe / Cruthaithe: (2022-12-01)

Imaging-based analysis of antibody superagonism
de réir: Aßmann, MC
Foilsithe / Cruthaithe: (2016)

Autotaxin suppresses cytotoxic T cells via LPAR5 to promote anti–PD-1 resistance in non–small cell lung cancer
de réir: Jessica M. Konen, et al.
Foilsithe / Cruthaithe: (2023-09-01)

Intraperitoneal injection of class A TLR9 agonist enhances anti–PD-1 immunotherapy in colorectal peritoneal metastases
de réir: Ting Jiang, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Modulators of MHC class I-related protein 1-mediated antigen presentation
de réir: Kulicke, CA
Foilsithe / Cruthaithe: (2018)

Modulation of receptor for advanced glycation end products signal transduction pathway as therapeutic option for malaria therapy
de réir: Chuah, Yaw Kuang
Foilsithe / Cruthaithe: (2015)

Mechanisms of co-stimulatory and inhibitory receptors in human cancer-specific cytotoxic T cells
de réir: Bin Abd Hamid, M
Foilsithe / Cruthaithe: (2019)

Balanced engagement of activating and inhibitory receptors mitigates human NK cell exhaustion
de réir: Jacob A. Myers, et al.
Foilsithe / Cruthaithe: (2022-08-01)

Rigid, bivalent CTLA-4 binding to CD80 is required to disrupt the cis CD80/PD-L1 interaction
de réir: Maximillian A. Robinson, et al.
Foilsithe / Cruthaithe: (2024-09-01)

Decitabine priming increases anti–PD-1 antitumor efficacy by promoting CD8+ progenitor exhausted T cell expansion in tumor models
de réir: Xiang Li, et al.
Foilsithe / Cruthaithe: (2023-04-01)

Acod1 expression in cancer cells promotes immune evasion through the generation of inhibitory peptides
de réir: James H. Schofield, et al.
Foilsithe / Cruthaithe: (2024-04-01)

The diversity of inhibitory receptor co-expression patterns of exhausted CD8+ T cells in oropharyngeal carcinoma
de réir: Yufang Rao, et al.
Foilsithe / Cruthaithe: (2024-05-01)

Structural development of the HIV-1 apex-directed PGT145-PGDM1400 antibody lineage
de réir: Rosemarie D. Mason, et al.
Foilsithe / Cruthaithe: (2025-01-01)

Immunogen characterization reveals an intrinsic hindrance in eliciting neutralizing antibodies against JN.1 variant
de réir: Junhao Fan, et al.
Foilsithe / Cruthaithe: (2024-08-01)

mTOR regulates T cell exhaustion and PD-1–targeted immunotherapy response during chronic viral infection
de réir: Satomi Ando, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Antibody applications : essential techniques /
de réir: 211968 Delves, Peter J.
Foilsithe / Cruthaithe: (1995)

Large-scale antibody immune response mapping of splenic B cells and bone marrow plasma cells in a transgenic mouse model
de réir: Pan, Xiaoli, et al.
Foilsithe / Cruthaithe: (2023)

Development and characterisation of human monoclonal antibodies against the Ebola virus glycoprotein
de réir: Mendelsohn, S
Foilsithe / Cruthaithe: (2014)

Stringent and complex sequence constraints of an IGHV1-69 broadly neutralizing antibody to influenza HA stem
de réir: Qi Wen Teo, et al.
Foilsithe / Cruthaithe: (2023-11-01)

2'-Deoxyadenosine 5'-diphosphoribose is an endogenous TRPM2 superagonist.
de réir: Fliegert, R, et al.
Foilsithe / Cruthaithe: (2017)